Not independent
Tenure on this board
New nominee
8 nominees · 2 ballot items.
Two management proposals: (1) authorize an amendment to the Certificate of Incorporation to permit a reverse stock split of outstanding common stock at a ratio between 1-for-2 and 1-for-2,000 to be set by the Board within one year; and (2) authorize an amendment to the Certificate of Incorporation to increase the total authorized capital stock to 1,001,000,000 shares (1,000,000,000 common) and decrease par value to $0.0001 per share.
Authorize the Board to amend the Certificate of Incorporation to implement a reverse stock split of all outstanding common shares at a ratio between one-for-two and one-for-two thousand (1-for-2 to 1-for-2000), to be set by the Board within one year, primarily to regain Nasdaq minimum bid price compliance and to ensure sufficient authorized shares for warrants and convertible securities.
This management proposal asks shareholders to permit the Board to amend the Company’s Certificate of Incorporation to effect a reverse stock split of all outstanding common shares at a ratio selectable by the Board anywhere between 1-for-2 and 1-for-2,000, exercisable within one year after approval. Management is seeking this authority primarily in response to a Nasdaq notice that the Company is not in compliance with the $1.00 minimum bid price listing requirement; the Board intends to use the reverse split as a tactical tool to raise the per-share trading price and regain compliance within the 180-day cure period. The Board also cites a secondary purpose: to ensure sufficient authorized shares remain available to satisfy exercise and conversion demands from outstanding warrants and convertible securities following any ratio selection. The range of ratios gives the Board flexibility to choose a split tailored to contemporaneous market conditions, trading volume, and capital-raising needs without needing a further shareholder vote. While the Board expects the reverse split to increase the per-share price, it acknowledges the outcome is uncertain and could fail to produce sustained compliance or could reduce liquidity through fewer outstanding shares. The proposal preserves stockholder proportional ownership (aside from fractional-share adjustments) and contemplates rounding up fractional shares, with no dissenters’ rights under Delaware law. From a governance perspective, the proposal increases the pool of unissued authorized shares (by reducing outstanding shares) which could be used for financings or incentives but also presents potential anti-takeover concerns if used opportunistically. The Board recommends a vote FOR, arguing the benefits—principally maintaining Nasdaq listing and operational flexibility—outweigh the risks, while stockholders should weigh potential dilution, liquidity impacts, and the market’s uncertain response when evaluating the measure.
Authorize the Board to amend the Certificate of Incorporation to increase total authorized capital stock from 46,000,000 (45,000,000 common and 1,000,000 preferred) to 1,001,000,000 (1,000,000,000 common and 1,000,000 preferred) and to decrease the par value of common and preferred stock from $0.01 to $0.0001 per share, to provide flexibility for financing, equity compensation and strategic transactions.
This management proposal requests shareholder approval to amend the Certificate of Incorporation to expand authorized capital from 46 million to 1,001 million total shares and to reduce par value from $0.01 to $0.0001 per share. Management frames this change as a tool to preserve flexibility for future equity financings, to support equity-based compensation programs, and to enable strategic transactions (such as acquisitions) without the delay or expense of seeking further shareholder approval. The par value reduction is an accounting and capital-structure measure intended to reclassify stated capital into additional paid-in capital, facilitating future issuances without materially changing total stockholders’ equity. Although the Board asserts there are no current plans to issue the additional shares, the amendment would materially increase the number of authorized but unissued shares available to the Board, which could be employed for fundraising, employee awards, or other corporate actions that would dilute existing holders if and when issued. The company acknowledges potential adverse effects, including dilution of earnings per share and voting power, and discloses the theoretical anti-takeover implications of increasing authorized shares, though the Board disclaims any intent to use the amendment for that purpose. The vote required under Delaware law is a majority of outstanding shares, and abstentions/broker non-votes will count against approval; the Board recommends a vote FOR based on operational flexibility benefits. Sophisticated investors should balance the immediate lack of dilutive action against the longer-term risk that the Board could opportunistically issue shares, and consider negotiating safeguards or monitoring issuance authorizations post-approval.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | GEODE CAPITAL MANAGEMENT, LLC | 0.38% | 55,104 | $38K |
| 2 | VANGUARD FIDUCIARY TRUST CO | 0.16% | 23,285 | $16K |
| 3 | NORTHERN TRUST CORP | 0.15% | 21,639 | $15K |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 0.07% | 9,987 | $7K |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 0.05% | 7,603 | $5K |
| 6 | Tower Research Capital LLC (TRC | 0.01% | 723 | $496 |
| 7 | UBS Group AG | 0.00% | 532 | $365 |
| 8 | BARCLAYS PLC | 0.00% | 339 | $233 |
| 9 | ROYAL BANK OF CANADA | 0.00% | 3 | $2 |
| 10 | Caitong International Asset Management Co., Ltd | 0.00% | 1 | $1 |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.